Similar articles

• High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective?

  Santamato A, Ranieri M, Solfrizzi V, Lozupone M, Vecchio M, Daniele A, Greco A, Seripa D, Logroscino G, Panza F. Santamato A, et al. Expert Opin Drug Metab Toxicol. 2016 Aug;12(8):843-6. doi: 10.1080/17425255.2016.1198318. Epub 2016 Jun 17. Expert Opin Drug Metab Toxicol. 2016. PMID: 27291256 No abstract available.
• Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.

  Santamato A, Micello MF, Panza F, Fortunato F, Baricich A, Cisari C, Pilotto A, Logroscino G, Fiore P, Ranieri M. Santamato A, et al. J Neurol Sci. 2014 Dec 15;347(1-2):39-43. doi: 10.1016/j.jns.2014.09.016. Epub 2014 Sep 19. J Neurol Sci. 2014. PMID: 25263601 Clinical Trial.
• Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.

  Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, Lee CH, Jenkins S, Turkel C; Botox Post-Stroke Spasticity Study Group. Brashear A, et al. N Engl J Med. 2002 Aug 8;347(6):395-400. doi: 10.1056/NEJMoa011892. N Engl J Med. 2002. PMID: 12167681 Clinical Trial.
• [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].

  Madsen ES, Sonne-Holm S, Wong C, Curtis D, Bencke J. Madsen ES, et al. Ugeskr Laeger. 2015 Jan 12;177(3):V07140409. Ugeskr Laeger. 2015. PMID: 25613095 Review. Danish.
• [The use of botulotoxin type A(dysport)in the complex therapy of patients with post-stroke spasticity].

  Khat'kova SE. Khat'kova SE. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(12):57-9. Zh Nevrol Psikhiatr Im S S Korsakova. 2008. PMID: 19255982 Review. Russian. No abstract available.